Multi-center evaluation of analytical performance of the microparticle enzyme immunoassay for sirolimus.

[1]  D. Holt,et al.  The relative proportions of sirolimus metabolites in blood using HPLC with mass-spectrometric detection. , 2004, Transplantation proceedings.

[2]  D. Cooper,et al.  High-Throughput Liquid Chromatography-Tandem Mass Spectrometric Analysis of Sirolimus in Whole Blood , 2003, Clinical chemistry and laboratory medicine.

[3]  W. Bablok,et al.  A New Biometrical Procedure for Testing the Equality of Measurements from Two Different Analytical Methods. Application of linear regression procedures for method comparison studies in Clinical Chemistry, Part I , 1983, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[4]  L. Shaw,et al.  Advances in therapeutic drug monitoring for immunosuppressants: a review of sirolimus. Introduction and overview. , 2000, Clinical therapeutics.

[5]  Cass J. Grandone,et al.  The Abbott IMx automated benchtop immunochemistry analyzer system. , 1988, Clinical chemistry.

[6]  B. Kahan,et al.  Routine clinical monitoring of sirolimus (rapamycin) whole-blood concentrations by HPLC with ultraviolet detection. , 1996, Clinical chemistry.

[7]  G. Barnes,et al.  Inter-laboratory differences in sirolimus results from six sirolimus testing centers using HPLC tandem mass spectrometry (LC/MS/MS). , 2005, Clinica chimica acta; international journal of clinical chemistry.

[8]  D. Holt,et al.  Therapeutic monitoring of sirolimus: its contribution to optimal prescription. , 2003, Transplantation proceedings.

[9]  H. Meier‐Kriesche,et al.  Toxicity and efficacy of sirolimus: relationship to whole-blood concentrations. , 2000, Clinical therapeutics.

[10]  P. Taylor,et al.  Quantitative analysis of sirolimus (Rapamycin) in blood by high-performance liquid chromatography-electrospray tandem mass spectrometry. , 1998, Journal of chromatography. B, Biomedical sciences and applications.

[11]  D. Holt,et al.  Measurement of sirolimus in whole blood using high-performance liquid chromatography with ultraviolet detection. , 2000, Clinical therapeutics.

[12]  H. Schiebel,et al.  Isolation of two immunosuppressive metabolites after in vitro metabolism of rapamycin. , 1992, Drug metabolism and disposition: the biological fate of chemicals.

[13]  S. Maleki,et al.  Therapeutic monitoring of sirolimus in human whole-blood samples by high-performance liquid chromatography. , 2000, Clinical therapeutics.

[14]  H. Schiebel,et al.  Sensitive and specific quantification of sirolimus (rapamycin) and its metabolites in blood of kidney graft recipients by HPLC/electrospray-mass spectrometry. , 1996, Clinical chemistry.

[15]  U. Christians,et al.  Cytochrome P-450 3A enzymes are responsible for biotransformation of FK506 and rapamycin in man and rat. , 1992, Drug metabolism and disposition: the biological fate of chemicals.

[16]  D. Holt,et al.  Validation of an assay for routine monitoring of sirolimus using HPLC with mass spectrometric detection. , 2000, Clinical chemistry.

[17]  B D Kahan,et al.  Clinical Pharmacokinetics of Sirolimus , 2001, Clinical pharmacokinetics.

[18]  V. Armstrong,et al.  Rapid liquid chromatography-tandem mass spectrometry routine method for simultaneous determination of sirolimus, everolimus, tacrolimus, and cyclosporin A in whole blood. , 2002, Clinical chemistry.

[19]  N. Nakashima,et al.  Analytical Performance of Microparticle Enzyme Immunoassay and HPLC-Tandem Mass Spectrometry in the Determination of Sirolimus in Whole Blood , 2022 .

[20]  N. Perico,et al.  Assessment of sirolimus concentrations in whole blood by high-performance liquid chromatography with ultraviolet detection. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[21]  D. Holt,et al.  An immunoassay for the measurement of sirolimus. , 2000, Clinical therapeutics.

[22]  U. Christians,et al.  Metabolism and transport of the macrolide immunosuppressant sirolimus in the small intestine. , 1998, The Journal of pharmacology and experimental therapeutics.

[23]  P. Taylor,et al.  The quantification of sirolimus by high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in renal transplant recipients. , 2000, Clinical therapeutics.

[24]  H. Schiebel,et al.  Structural identification of three metabolites and a degradation product of the macrolide immunosuppressant sirolimus (rapamycin) by electrospray-MS/MS after incubation with human liver microsomes. , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[25]  J. Zimmerman,et al.  Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus. , 2000, Clinical therapeutics.